COMMUNIQUÉS West-GlobeNewswire

PSIQ to Receive Assignment of License to Prepare Land in Israel With the Intent to Grow, Cultivate, Distribute and Export Medical Cannabis to the Projected $57 Billion Global Legal Cannabis Market
27/03/2019
SUNRISE, Fla., March 27, 2019 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) is pleased to announce the signing of a letter of intent for the assignment of a temporary license to prepare farm located at [...]
Frost & Sullivan recognizes Allscripts with 2019 Best Practices Award
27/03/2019
Analyst firm honors Allscripts for Population Health Management – United States CHICAGO, March 27, 2019 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) has been recognized by Frost & Sullivan with the 2019 Best [...]
Kaleido Biosciences Announces Upcoming Presentations at the Society for Inherited Metabolic Disorders Annual Meeting and The International Liver Congress™ (EASL)
27/03/2019
Posters to feature ex vivo and in-human data supporting Kaleido’s Microbiome Metabolic Therapy programs for the treatment of hyperammonemia LEXINGTON, Mass., March 27, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc [...]
Ceapro Announces Acceptance of Abstract for Presentation at the 2019 American College of Sports Medicine Annual Meeting
27/03/2019
EDMONTON, Alberta, March 27, 2019 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for [...]
TRACON Pharmaceuticals Announces TRC105, TRC253 and TRC102 Data Presentations at Upcoming AACR Annual Meeting
27/03/2019
SAN DIEGO, March 27, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]
CrownBio and Hubrecht Organoid Technology Announce a Strategic Partnership, including Exclusive License to Provide Oncology Organoid-Based Preclinical Drug Development and Validation Services
27/03/2019
Partnership combines breakthrough organoid technology with the world’s largest PDX collection to create a unique patient-derived translational research platform SAN DIEGO, March 27, 2019 (GLOBE NEWSWIRE) -- Crown [...]
Allena Pharmaceuticals Announces Agreement with Duke Clinical Research Institute for URIROX-2 Pivotal Phase 3 Trial
27/03/2019
Duke to Establish and Lead an Academic Coordinating Center for Phase 3 URIROX-2 Trial of Reloxaliase in Patients with Enteric Hyperoxaluria NEWTON, Mass., March 27, 2019 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc [...]
Rexahn Announces Multiple Presentations at the 2019 American Association for Cancer Research Annual Meeting
27/03/2019
ROCKVILLE, M.D., March 27, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical-stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers [...]
Integrated Cannabis Company Provides Corporate Update
27/03/2019
VANCOUVER, British Columbia, March 27, 2019 (GLOBE NEWSWIRE) -- Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“ Integrated Cannabis ” or the “ Company ”), is pleased to provide a corporate update. The [...]
Progressive Care to Host Conference Call on the 2018 Annual Report and Business Update on March 28, 2019
27/03/2019
MIAMI, March 27, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, is pleased to announce that the Company has scheduled an investor conference [...]
Biotricity Achieves Market Expansion in Two New States
27/03/2019
REDWOOD CITY, Calif., March 27, 2019 (GLOBE NEWSWIRE) -- Biotricity Inc. ( OTCQB : BTCY ), a medical diagnostic and consumer healthcare technology company, has expanded its sales team to cover two additional states in [...]
Guardant Health Announces Definitive Agreement to Acquire Bellwether Bio
27/03/2019
REDWOOD CITY, Calif., March 27, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), announced that it has entered into a definitive agreement to acquire Bellwether Bio, Inc., a privately held company focused on [...]
Imvax to Present Results from Phase 1b Clinical Trial of IGV-001 in Glioblastoma Multiforme at the American Association for Cancer Research Annual Meeting 2019
27/03/2019
PHILADELPHIA, March 27, 2019 (GLOBE NEWSWIRE) -- Imvax, Inc., a clinical-stage biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies, announced today that [...]
Todos Medical Appoints Dr. Colin Bier to Its Board of Directors
27/03/2019
REHOVOT, Israel, March 27, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer and [...]
Veritas Pharma Provides Corporate Update
27/03/2019
VANCOUVER, British Columbia, March 27, 2019 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce corporate highlights and to communicate [...]
CymaBay Therapeutics Announces Multiple Presentations During The International Liver Conference™ 2019
27/03/2019
Oral presentation will feature clinical data for seladelpar in primary biliary cholangitis (PBC) patients with cirrhosis NEWARK, Calif., March 27, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), today [...]
Precipio Receives Expected Delisting Determination from Nasdaq Staff and Will Request Nasdaq Hearing
27/03/2019
NEW HAVEN, Conn., March 27, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ) today announced that it has received the expected delisting determination from Nasdaq Staff. The Company [...]
MediPharm Labs Sets Date to Release Fourth Quarter and Full Year 2018 Financial Results
27/03/2019
TORONTO, March 27, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, [...]
NEOVACS STRENGTHENS ITS FINANCIAL STRUCTURE: ISSUANCE OF "ORNANE" FOR A MAXIMUM AMOUNT OF €10M, WITHOUT STOCK SUBSCRIPTION WARRANTS
27/03/2019
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE N E OVACS STRENGTHENS ITS FINANCIAL STRUCTURE: ISSUANCE OF "ORNANE" FOR A MAXIMUM AMOUNT OF €10M, WITHOUT STOCK SUBSCRIPTION WARRANTS Paris and Boston, March 25 th 2019 - 7: [...]

Pages